A modified version of Interferon-beta1a, recently approved for the treatment of relapsing remitting MS by both the European

Magnetic Resonance Imaging (MRI) scans of brain and spinal cord perform a vital role in the diagnosis and

An article published in the international journal Glia gives new insight into the structure of lesions in the

Over the last decade MS Research Australia has supported several important Australian studies that have contributed to the

MS Research Australia has joined the USA, UK, Italy, Denmark, Spain and Canada in a global alliance to

Recent research published in the journal Nature Communicationsreports on a novel way to ‘switch off’ the autoimmune response

A number of international studies have previously shown that the risk of developing MS is slightly higher in

Researchers in the Canadian State of Manitoba, have conducted a study of the health claims data for over

Up to 60% of people with MS experience falls, and a large proportion of these falls result in